This is the third competing renewal for our Training in Virology T32 program, which is a combination of previously separate Pre- and Postdoctoral training grants that were merged into a single program during the last competitive renewal. Our Training in Virology Program uses the facilities of the University of Pennsylvania (Medical, Dental, and Vet Schools), the Wistar Institute, and the Children's Hospital of Philadelphia, all of which share a compact, contiguous campus. Among our 34 NIH-funded virologists, a select group of 19 are trainers on this program, with 7 trainers being women or minorities. For the past 15 years, this program has supported 5 predoctoral and 3 postdoctoral trainees per year. Over the past funding period, this Virology T32 supported 14 predoctoral trainees (8 men, 6 women, 3 under-represented minorities) and 9 postdoctoral fellows (3 men, 6 women, 2 under-represented minorities). Thus, 52% of our trainees have been women, and 22% have been under-represented minorities. These 23 trainees worked in the labs of 19 different trainers. Our training program takes a direct and active role in minority recruitment - seven of our trainers have attended the ABRCMS or SACNAS meetings over the past three years, and a willingness to attend these meetings is a requirement for being a trainer on this grant. Many of our past trainees now hold positions in academics and industry, where they continue to study virology. At present, there are 39 postdoctoral (19 being T32-eligible) and 31 predoctoral (29 being T32-eligible) trainees being mentored by trainers associated with this virology T32, with most of these trainees studying topics that are directly relevant to our Virology Training Program. Thus, appointment to this T32 is highly competitive. Since our last competing renewal, our graduate program has nearly tripled in size, the fraction of our postdoctoral fellows who are T32-eligible has increased dramatically (to nearly 50%) in part through our program-specific recruitment efforts, the number of minority students entering our program has increased dramatically, new faculty have been hired, and research facilities expanded or renewed. However, given the current NIH funding situation coupled with our desire to remain highly selective, we propose to maintain our Training in Virology Program at its current size of 5 predoctoral and 3 postdoctoral trainees per year. Importantly, Penn continues to provide direct and tangible institutional commitment to training in the biomedical sciences by (among other things) funding the Biomedical Postdoctoral Programs office and by supported predoctoral trainees for their first 21 months of graduate school. Our trainers direct numerous program-specific training activities, from a very well attended weekly virology seminar series in which our trainees present their work, to updating our virology curriculum, instituting a new program to emphasize biostatistics and quantitative methods, and coordinating our very pro-active minority recruiting efforts. Our interactive and highly collaborative group of virologists, documented by numerous joint publications, lab meetings and grants, provide an unusually broad training environment for our outstanding group of pre- and postdoctoral trainees.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Schools of Medicine
United States
Zip Code
Han, Ziying; Bart, Stephen M; Ruthel, Gordon et al. (2016) Ebola virus mediated infectivity is restricted in canine and feline cells. Vet Microbiol 182:102-7
Birdwell, L Dillon; Zalinger, Zachary B; Li, Yize et al. (2016) Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon. J Virol 90:3160-72
Molleston, Jerome M; Sabin, Leah R; Moy, Ryan H et al. (2016) A conserved virus-induced cytoplasmic TRAMP-like complex recruits the exosome to target viral RNA for degradation. Genes Dev 30:1658-70
Bradley, William P; Boyer, Mark A; Nguyen, Hieu T et al. (2016) Primary Role for Toll-Like Receptor-Driven Tumor Necrosis Factor Rather than Cytosolic Immune Detection in Restricting Coxiella burnetii Phase II Replication within Mouse Macrophages. Infect Immun 84:998-1015
Ocwieja, Karen E; Sherrill-Mix, Scott; Liu, Changchun et al. (2015) A reverse transcription loop-mediated isothermal amplification assay optimized to detect multiple HIV subtypes. PLoS One 10:e0117852
Vande Burgt, Nathan H; Kaletsky, Rachel L; Bates, Paul (2015) Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism. Viruses 7:5587-602
Zalinger, Zachary B; Elliott, Ruth; Rose, Kristine M et al. (2015) MDA5 Is Critical to Host Defense during Infection with Murine Coronavirus. J Virol 89:12330-40
Drake, Mary Jane; Bates, Paul (2015) Application of gene-editing technologies to HIV-1. Curr Opin HIV AIDS 10:123-7
Mitchell, Angela M; Stone, Amy E L; Cheng, Linling et al. (2015) Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver. MBio 6:e02510
Stoddard, Mark B; Li, Hui; Wang, Shuyi et al. (2015) Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4. MBio 6:e02518

Showing the most recent 10 out of 80 publications